Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.J Thromb Haemost. 2015; 13: 2012-2020
- Dabigatran and postmarketing reports of bleeding.N Engl J Med. 2013; 368: 1272-1274
- Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.J Am Soc Nephrol. 2014; 25: 431-442
- Non-VKA oral anticoagulants and antiplatelet therapy for stroke prevention in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.Cardiol Rev. Aug 11 2015; ([Epub ahead of print])
- Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.Eur Heart J. 2015; 36: 1264-1272
- Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.Circulation. 2013; 127: 634-640
- Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.J Thromb Haemost. 2014; 12: 320-328
- Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.Thromb Res. 2014; 134: 7747-7782
- ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med. 2011; 365: 981-992
- ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.N Engl J Med. 2011 Sep 8; 365: 883-891